Home About us Editorial board Ahead of print Current issue Archives Submit article Instructions Subscribe Search Contacts Login 
  • Users Online: 1284
  • Home
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2010  |  Volume : 22  |  Issue : 1  |  Page : 10-17

A Comparative Study between Oxcarbazepine and Gabapentin Regarding Therapeutic Efficiency and Tolerability in the Treatment of Trigeminal Neuralgia


1 Department of Oral Median and Radiology, Chhattisgarh Dental College and Research Institute, Sundra Rajnandgaon, Chhattisgarh, India
2 Department of Oral Medicine and Radiology, Chhattisgarh Dental College and Research Institute, Sundra Rajnandgaon, Chhattisgarh, India
3 Department of Oral Diagnosis, Medicine and Radiology, Government Dental College and Hospital, Ahmedabad Gujarat, India
4 Department of Oral Pathology, Chhattisgarh Dental College and Research Institute, Sundra, Rajnandgaon Chhattisgarh, India

Correspondence Address:
Fakir Mohan Debta
Department of Oral Medicine and Radiology, Chhattisgarh Dental College and Research Institute, Staff Quarter, No. 8/16, College Campus, PB No. 25, Sundra, Rajnandgaon, Chhattisgarh-491441
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Trigerninal neuralgia is a relapsing and remittent disorder is best symptomatically treated by medical treatment out of which carbamazepine thought to be a diagnostic drug marker of trigeminal neuralgia, has often undesirable side effects and sometimes ineffective, limiting its usage, thus search for more effective drug with lesser side effect is still on. Recently two newer anticonvulsant oxcarbazepine (OXC) a ketoderivative of carbamazepine and gabapentin (GBP) has been trailed in trigeminal neuralgia in different open clinical trial as monotherapy with encouraging results. These drugs have convenient dosage and surprisingly fewer side effects. These facts that trigeminal neuralgia responds to newer anticonvulsant (oxcarbazepine, gabapentin) in a better perspective, enabled me to conduct the present clinical trial on 54 patients (both in newly diagnosed TN patient and refractive patient) of trigeminal neuralgia who were made two randomized group for separate monotherapy study for a period of six months. The therapeutic effect of OXC and gabapentin (GBP) in relation to reduction in number of attacks of pain and severity of pain were evaluated. All the scoring data showed OXC is more therapeutic efficacious cost-effective and well-tolerated profile than gabapentin and an emerging as a drug for treatment of TN in both new and refractive patients.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed366    
    Printed6    
    Emailed0    
    PDF Downloaded159    
    Comments [Add]    

Recommend this journal